Search bioRxiv⌕ Search

Biology subjects

Saquel, C.

Publications and source records attributed to Saquel, C..

2 recordsLinked to original sources

Caveolin-1 and mechanical stress control the release of a pro-metastatic subpopulation of small extracellular vesicles

Mechanical forces within the tumor microenvironment critically influence cancer progression, in part by modulating extracellular vesicle (EV) dynamics. However, the molecular mechanisms by which EVs respond to mechanical cues remain poorly understood. Here, we identify caveolin-1 (Cav1), a core structural component of caveolae, specialized membrane invaginations that act as mechanosensors, as a key regulator of EV release and composition under mechanical stress. We demonstrate that both 2D osmotic shock and 3D mechanical compression significantly enhance EV secretion from cancer cells in a Cav1-dependent manner. These EVs exhibit a distinct lipid profile and are selectively enriched in proteins involved in cell adhesion, motility, wound healing and extracellular matrix remodeling, cargo that is lost upon Cav1 deletion. Functionally, EVs secreted from mechanically stressed cells preferentially accumulate in the liver in vivo and promote breast cancer cell migration and invasion in vitro, effects abolished in the absence of Cav1. Together, these findings reveal a previously unrecognized role for Cav1 in coupling mechanical stress to EV biogenesis and cargo loading, thereby promoting metastatic traits. This study underscores a novel mechanism by which mechanical cues within tumor environment regulate EV-mediated communication and suggests that Cav1-enriched EVs may contribute to pre-metastatic niche formation.

cancer biology↗

The necroptosis machinery mediates axonal degeneration in a model of Parkinson disease

Parkinsons disease (PD) is the second most common neurodegenerative condition, characterized by motor impairment due to the progressive degeneration of dopaminergic neurons in the substantia nigra and depletion of dopamine release in the striatum. Accumulating evidence suggest that degeneration of axons is an early event in the disease, involving destruction programs that are independent of the survival of the cell soma. Necroptosis, a programmed cell death process, is emerging as a mediator of neuronal loss in models of neurodegenerative diseases. Here, we demonstrate activation of necroptosis in postmortem brain tissue from PD patients and in a toxin-based mouse model of the disease. Inhibition of key components of the necroptotic pathway resulted in a significant delay of 6-hydroxydopamine dependent axonal degeneration of dopaminergic and cortical neurons in vitro. Genetic ablation of necroptosis mediators MLKL and RIPK3, as well as pharmacological inhibition of RIPK1 in vivo, decreased dopaminergic neuron degeneration, improving motor performance. Together, these findings suggest that axonal degeneration in PD is mediated by the necroptosis machinery, a process here referred to as necroaxoptosis, a druggable pathway to target dopaminergic neuronal loss.

neuroscience↗